What is the treatment for diabetic ketoacidosis (DKA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Diabetic Ketoacidosis (DKA)

The standard treatment for diabetic ketoacidosis requires fluid resuscitation with isotonic saline followed by continuous intravenous insulin infusion at 0.1 units/kg/hour without an initial bolus, along with appropriate electrolyte replacement and monitoring. 1

Diagnostic Criteria

  • Blood glucose >250 mg/dL
  • Arterial pH <7.3
  • Bicarbonate <15 mEq/L
  • Moderate ketonemia or ketonuria

DKA severity classification:

Parameter Mild Moderate Severe
Arterial pH 7.25-7.30 7.00-7.24 <7.00
Bicarbonate (mEq/L) 15-18 10-14 <10
Mental Status Alert Alert/drowsy Stupor/coma

Treatment Algorithm

1. Fluid Therapy

  • Initial resuscitation: Isotonic saline at 15-20 ml/kg/hour for the first hour 1
  • Subsequent fluid therapy: 0.45% saline at 4-14 ml/kg/hour based on corrected sodium levels 1
  • Newer evidence: Balanced crystalloid solutions may lead to faster resolution of acidosis than normal saline 2, 3
  • Calculate corrected sodium using: Measured sodium + 1.6 × [(glucose mg/dl - 100)/100] 1

2. Insulin Administration

  • Standard approach: Continuous IV regular insulin at 0.1 units/kg/hour without an initial bolus 1, 4
    • Avoids rapid glucose reduction and risk of cerebral edema
    • Continue until DKA resolution (glucose <200 mg/dL, bicarbonate ≥18 mEq/L, pH >7.3) 1
  • Alternative for uncomplicated DKA: Subcutaneous rapid-acting insulin analogs in emergency departments or step-down units 1

3. Electrolyte Replacement

  • Potassium: Begin when serum K+ <5.5 mEq/L and adequate urine output is confirmed 1
    • Add 20-30 mEq/L potassium to IV fluids (2/3 KCl and 1/3 KPO₄)
    • Hypokalemia occurs in approximately 50% of patients during treatment
  • Phosphate: Generally included as KPO₄, especially with severe hypophosphatemia 1
  • Bicarbonate: Generally not recommended routinely
    • Consider only if pH <7.0, and then add to IV fluids rather than giving as bolus 2

4. Monitoring Protocol

  • Hourly monitoring:
    • Vital signs
    • Neurological status
    • Blood glucose
    • Fluid input/output
  • Every 2-4 hours:
    • Electrolytes
    • BUN and creatinine
    • Venous pH 1

Complications to Watch For

Cerebral Edema

  • Rare but potentially fatal (0.7-1.0% in children) 1
  • Prevention:
    • Avoid too rapid correction of serum osmolality (not exceeding 3 mOsm/kg/h)
    • Limit initial vascular expansion to 50 ml/kg in first 4 hours in pediatric patients 1
    • Monitor for headache, altered mental status, seizures, or bradycardia

Other Complications

  • Hypoglycemia: Monitor glucose closely during insulin infusion 4
  • Hypokalemia: Can develop rapidly during treatment 1, 4
  • Fluid overload: Particularly in patients with cardiac or renal disease 1

Resolution Criteria

DKA is considered resolved when:

  • Glucose <200 mg/dL
  • Serum bicarbonate ≥18 mEq/L
  • Venous pH >7.3 1

Post-Resolution Management

  • Identify and treat underlying causes (infection, missed insulin, new diagnosis) 1
  • Transition to subcutaneous insulin after DKA resolution
  • Provide education on:
    • Diabetes self-management
    • Blood glucose monitoring
    • Sick-day management
    • When to seek medical attention 1

Common Pitfalls

  1. Insulin bolus administration: Avoid initial bolus to prevent rapid glucose reduction and cerebral edema 1
  2. Inadequate fluid resuscitation: Underestimating volume depletion can delay recovery
  3. Neglecting potassium replacement: Can lead to dangerous hypokalemia during treatment 1, 4
  4. Overuse of bicarbonate: May worsen ketosis, hypokalemia, and increase risk of cerebral edema 2
  5. Premature discontinuation of IV insulin: Continue until DKA resolution criteria are met 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.